154 related articles for article (PubMed ID: 35748200)
21. Inhibin expression in ovarian-type stroma in mucinous cystic neoplasms of the pancreas.
Yeh MM; Tang LH; Wang S; Robert ME; Zheng W; Jain D
Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):148-52. PubMed ID: 15354741
[TBL] [Abstract][Full Text] [Related]
22. The "extracapsular cystic" sign in pancreatic serous cystic neoplasms: A clinicopathologic study of 177 patients with cystic pancreatic lesions.
Chen HY; Zhao J; Lu YF; Lv SY; Chen JY; Pan Y; Shi D; Xu XF; Yu RS
Eur J Radiol; 2018 Sep; 106():167-172. PubMed ID: 30150040
[TBL] [Abstract][Full Text] [Related]
23. Preoperative differentiation of pancreatic mucinous cystic neoplasm from macrocystic serous cystic adenoma using radiomics: Preliminary findings and comparison with radiological model.
Xie H; Ma S; Guo X; Zhang X; Wang X
Eur J Radiol; 2020 Jan; 122():108747. PubMed ID: 31760275
[TBL] [Abstract][Full Text] [Related]
24. Cyst fluid analysis obtained by EUS-guided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience.
Linder JD; Geenen JE; Catalano MF
Gastrointest Endosc; 2006 Nov; 64(5):697-702. PubMed ID: 17055859
[TBL] [Abstract][Full Text] [Related]
25. Hypervascular solid-appearing serous cystic neoplasms of the pancreas: Differential diagnosis with neuroendocrine tumours.
Park HS; Kim SY; Hong SM; Park SH; Lee SS; Byun JH; Kim JH; Kim HJ; Lee MG
Eur Radiol; 2016 May; 26(5):1348-58. PubMed ID: 26328927
[TBL] [Abstract][Full Text] [Related]
26. Differential Diagnosis of Pancreatic Epidermoid Cyst Without a Solid Component (Residual Splenic Tissue) vs. Mucinous Cystic Neoplasm.
Ishigami K; Nishie A; Irie H; Asayama Y; Ushijima Y; Takayama Y; Okamoto D; Fujita N; Ohtsuka T; Ito T; Mochidome N; Honda H
J Gastrointest Cancer; 2019 Mar; 50(1):91-97. PubMed ID: 29218653
[TBL] [Abstract][Full Text] [Related]
27. Mucinous cystic neoplasms of the pancreas: how much preoperative evaluation is needed?
Theruvath TP; Morgan KA; Adams DB
Am Surg; 2010 Aug; 76(8):812-7. PubMed ID: 20726409
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic cystic neoplasms and post-inflammatory cysts: interobserver agreement and diagnostic performance of MRI with MRCP.
Tirkes T; Patel AA; Tahir B; Kim RC; Schmidt CM; Akisik FM
Abdom Radiol (NY); 2021 Sep; 46(9):4245-4253. PubMed ID: 34014363
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic Mucinous Cystic Neoplasm Communicating with Main Pancreatic Duct: An Unrecognized Presentation of Pancreatic Mucinous Neoplasm?
Zhou W; Saam T; Zhou Y; Trevino J; Liu X; Cao D; Lai J
Anticancer Res; 2017 Dec; 37(12):7017-7021. PubMed ID: 29187489
[TBL] [Abstract][Full Text] [Related]
30. Management of Undifferentiated Solitary Mucinous Cystic Lesion of the Pancreas: A Clinical Dilemma.
Roch AM; Bigelow K; Schmidt CM; Carr RA; Jester AL; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
J Am Coll Surg; 2017 Apr; 224(4):717-723. PubMed ID: 28126546
[TBL] [Abstract][Full Text] [Related]
31. Mucinous cystic neoplasms of the pancreas: definition of preoperative imaging criteria for high-risk lesions.
Le Baleur Y; Couvelard A; Vullierme MP; Sauvanet A; Hammel P; Rebours V; Maire F; Hentic O; Aubert A; Ruszniewski P; Lévy P
Pancreatology; 2011; 11(5):495-9. PubMed ID: 22042244
[TBL] [Abstract][Full Text] [Related]
32. Mucinous cystic neoplasms of the pancreas: imaging features and diagnostic difficulties.
Scott J; Martin I; Redhead D; Hammond P; Garden OJ
Clin Radiol; 2000 Mar; 55(3):187-92. PubMed ID: 10708611
[TBL] [Abstract][Full Text] [Related]
33. Mucinous cystic neoplasms and serous cystadenomas arising in the body-tail of the pancreas: MR imaging characterization.
Manfredi R; Ventriglia A; Mantovani W; Mehrabi S; Boninsegna E; Zamboni G; Salvia R; Pozzi Mucelli R
Eur Radiol; 2015 Apr; 25(4):940-9. PubMed ID: 25417125
[TBL] [Abstract][Full Text] [Related]
34. [Difficulties of differential diagnosis of pancreatic pseudocysts and cystic neoplasms].
Zdanyte E; Strupas K; Bubnys A; Stratilatovas E
Medicina (Kaunas); 2004; 40(12):1180-8. PubMed ID: 15630345
[TBL] [Abstract][Full Text] [Related]
35. CT attenuation of unilocular pancreatic cystic lesions to differentiate pseudocysts from mucin-containing cysts.
Chalian H; Töre HG; Miller FH; Yaghmai V
JOP; 2011 Jul; 12(4):384-8. PubMed ID: 21737901
[TBL] [Abstract][Full Text] [Related]
36. Prediction of the Probability of Malignancy in Mucinous Cystic Neoplasm of the Pancreas With Ovarian-Type Stroma: A Nationwide Multicenter Study in Japan.
Ohtsuka T; Nakamura M; Hijioka S; Shimizu Y; Unno M; Tanabe M; Nagakawa Y; Takaori K; Hirono S; Gotohda N; Kimura W; Ito K; Katanuma A; Sano T; Urata T; Kita E; Hanada K; Tada M; Aoki T; Serikawa M; Okamoto K; Isayama H; Gotoh Y; Ishigami K; Yamaguchi H; Yamao K; Sugiyama M; Okazaki K
Pancreas; 2020 Feb; 49(2):181-186. PubMed ID: 32011526
[TBL] [Abstract][Full Text] [Related]
37. A serous oligocystic adenoma of the head of the pancreas successfully treated by dome resection and chemocautery: a new approach to serous oligocystic adenoma.
Sakata K; Maeda Y; Harada T; Nagashima J; Ueda M; Shimabukuro T; Sugano M; Nishizawa H; Fukuyama N; Kawashima M; Noguchi T; Iida Y; Yokota T
J Hepatobiliary Pancreat Surg; 2003; 10(6):446-9. PubMed ID: 14714166
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of 113 cases with mucinous cystic neoplasms in a single institutional study].
Xu MY; Shi XJ; Lu F; Wan T; Wang HG; Chen MY; He L; Shi HD
Zhonghua Wai Ke Za Zhi; 2016 Mar; 54(3):196-200. PubMed ID: 26932888
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical analysis of steroidogenic enzymes in ovarian-type stroma of pancreatic mucinous cystic neoplasms: Comparative study of subepithelial stromal cells in intraductal papillary mucinous neoplasms of the pancreas.
Ishida K; Sasano H; Moriya T; Takahashi Y; Sugimoto R; Mue Y; Murakami K; Fujishima F; Nakamura Y; Morikawa T; Motoi F; Suzuki T; Unno M; Sugai T
Pathol Int; 2016 May; 66(5):281-7. PubMed ID: 27060902
[TBL] [Abstract][Full Text] [Related]
40. Mucinous Cystic Neoplasms Lined by Abundant Mucinous Epithelium Frequently Involve KRAS Mutations and Malignant Progression.
Shibata H; Ohike N; Norose T; Isobe T; Suzuki R; Imai H; Shiokawa A; Aoki T; Murakami M; Mizukami H; Tanaka JI; Takimoto M
Anticancer Res; 2017 Dec; 37(12):7063-7068. PubMed ID: 29187496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
